Listed

Madrigal Pharmaceuticals, Inc.

MDGLNasdaqCIK 1157601HealthcareFiscal year ends Dec 31

Reports and events: 322 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Madrigal Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2023-11-2117:24 ETSC 13D/AOwnership report, active investor, amended0001104659-23-120429
2023-11-0608:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-270884
2023-11-0606:10 ET10-QQuarterly reportPeriod 2023-09-300001193125-23-270803
2023-10-0516:36 ETSC 13D/AOwnership report, active investor, amended0001104659-23-107213
2023-10-0217:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-249192
2023-09-2516:02 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-241315
2023-09-1416:31 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-235340
2023-09-1316:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-23-234395
2023-09-1316:25 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-234385
2023-08-0817:16 ETSC 13D/AOwnership report, active investor, amended0001104659-23-088894
2023-08-0808:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-205600
2023-08-0806:50 ET10-QQuarterly reportPeriod 2023-06-300001193125-23-205535
2023-07-1708:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-187698
2023-06-3008:00 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-23-179440
2023-06-2019:18 ETSC 13DOwnership report, active investor0001104659-23-072412
2023-06-2019:00 ET8-K5.02 Departure or appointment of officers or directors0001193125-23-169190
2023-06-2018:54 ET8-K5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-23-169187
2023-05-0908:16 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-23-138953
2023-05-0908:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-138931
2023-05-0906:51 ET10-QQuarterly reportPeriod 2023-03-310001193125-23-138863
2023-05-0109:11 ETDEF 14AProxy statement0001193125-23-128960
2023-03-0316:17 ET10-K/AAnnual report, amendedPeriod 2022-12-310001193125-23-060052
2023-02-2308:02 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-23-045671
2023-02-2306:32 ET10-KAnnual reportPeriod 2022-12-310001193125-23-045575
2023-02-0917:01 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-23-030281
2023-01-1017:00 ET8-K8.01 Other events0001193125-23-005674
2022-12-2307:00 ET8-K1.01 Entry into a material agreement; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-22-311537
2022-12-1908:42 ET8-K7.01 Regulation FD disclosure; 8.01 Other events0001193125-22-307935
2022-11-0308:56 ET10-QQuarterly reportPeriod 2022-09-300001193125-22-276468
2022-11-0308:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-276424
2022-08-0406:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-211760
2022-08-0406:31 ET10-QQuarterly reportPeriod 2022-06-300001193125-22-211757
2022-06-1712:33 ET8-K5.07 Shareholder vote results0001193125-22-176256
2022-05-0912:55 ET10-QQuarterly reportPeriod 2022-03-310001193125-22-144674
2022-05-0910:22 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity0001193125-22-144506
2022-05-0906:33 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-144230
2022-05-0211:40 ETDEF 14AProxy statementPeriod 2022-06-150001193125-22-136035
2022-02-2413:39 ET10-KAnnual reportPeriod 2021-12-310001193125-22-051569
2022-02-2408:01 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-22-051135
2021-12-0716:30 ETSC 13D/AOwnership report, active investor, amended0001193125-21-350295
2021-11-0408:30 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-319413
2021-11-0406:07 ET10-QQuarterly reportPeriod 2021-09-300001193125-21-319159
2021-08-0508:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-237087
2021-08-0506:51 ET10-QQuarterly reportPeriod 2021-06-300001193125-21-236933
2021-06-2110:56 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-21-194456
2021-06-0108:01 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-21-177871
2021-05-1808:30 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-21-164670
2021-05-0608:31 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-21-152675
2021-05-0606:10 ET10-QQuarterly reportPeriod 2021-03-310001193125-21-152386
2021-04-3015:59 ETDEF 14AProxy statementPeriod 2021-06-170001193125-21-144922

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 18:49 ET. Listed shows no prices and gives no investment advice.